1. Home
  2. NEWS
  3. Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint

Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint

Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint
Porosome Therapeutics Chairman Prof. Dr. Bhanu P. Jena and CEO Guillermo Marmol attended (by invitation only) “Translation 2026” at MIT.
Mechanism of action of Porosome Therapeutics Lead Alzheimer's Drug Explained in a 1 min Video - Copy
Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)